Zhen Pan

Direttore/Membro del Consiglio presso SHANGHAI GUIJIU CO.,LTD

41 anni

Consumer Services

Consumer Non-Durables

Health Technology

Profilo

Zhen Pan is currently working as a Director at Shanghai Guijiu Co., Ltd.
and as a Member-Supervisory Board at Hebei Yipin Pharmaceutical Co., Ltd.
He holds a Master's degree in Business Administration from Shanghai Jiao Tong University and an undergraduate degree from Shanghai University of Finance & Economics.

Posizioni attive di Zhen Pan

Società	Posizione	Inizio
SHANGHAI GUIJIU CO.,LTD	Direttore/Membro del Consiglio	01/09/2021
Hebei Yipin Pharmaceutical Co., Ltd. Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China.	Direttore/Membro del Consiglio	01/03/2021

Tutte le posizioni attive di Zhen Pan

Formazione di Zhen Pan

Shanghai Jiao Tong University	Masters Business Admin
Shanghai University of Finance & Economics	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Zhen Pan

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SHANGHAI GUIJIU CO.,LTD	Consumer Non-Durables

Aziende private	1
Hebei Yipin Pharmaceutical Co., Ltd. Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China.	Health Technology